Radiopharm Theranostics (RADX) Competitors $5.07 +0.36 (+7.64%) As of 12:35 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsOwnershipSEC FilingsTrendsBuy This Stock RADX vs. IOBT, GLSI, ACOG, CCCC, NVCT, THTX, CLLS, SPRO, CGEN, and GNLXShould you be buying Radiopharm Theranostics stock or one of its competitors? The main competitors of Radiopharm Theranostics include IO Biotech (IOBT), Greenwich LifeSciences (GLSI), Alpha Cognition (ACOG), C4 Therapeutics (CCCC), Nuvectis Pharma (NVCT), Theratechnologies (THTX), Cellectis (CLLS), Spero Therapeutics (SPRO), Compugen (CGEN), and Genelux (GNLX). These companies are all part of the "med - biomed/gene" industry. Radiopharm Theranostics vs. Its Competitors IO Biotech Greenwich LifeSciences Alpha Cognition C4 Therapeutics Nuvectis Pharma Theratechnologies Cellectis Spero Therapeutics Compugen Genelux IO Biotech (NASDAQ:IOBT) and Radiopharm Theranostics (NASDAQ:RADX) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk. Does the media prefer IOBT or RADX? In the previous week, IO Biotech had 11 more articles in the media than Radiopharm Theranostics. MarketBeat recorded 15 mentions for IO Biotech and 4 mentions for Radiopharm Theranostics. Radiopharm Theranostics' average media sentiment score of 0.75 beat IO Biotech's score of -0.07 indicating that Radiopharm Theranostics is being referred to more favorably in the news media. Company Overall Sentiment IO Biotech Neutral Radiopharm Theranostics Positive Which has preferable valuation & earnings, IOBT or RADX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIO BiotechN/AN/A-$95.49M-$1.49-0.80Radiopharm TheranosticsN/AN/AN/AN/AN/A Do analysts rate IOBT or RADX? IO Biotech presently has a consensus target price of $8.67, suggesting a potential upside of 625.85%. Radiopharm Theranostics has a consensus target price of $15.00, suggesting a potential upside of 195.86%. Given IO Biotech's higher probable upside, analysts plainly believe IO Biotech is more favorable than Radiopharm Theranostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IO Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Radiopharm Theranostics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Do institutionals & insiders believe in IOBT or RADX? 54.8% of IO Biotech shares are owned by institutional investors. 2.3% of IO Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is IOBT or RADX more profitable? Radiopharm Theranostics' return on equity of 0.00% beat IO Biotech's return on equity.Company Net Margins Return on Equity Return on Assets IO BiotechN/A -162.55% -125.08% Radiopharm Theranostics N/A N/A N/A SummaryIO Biotech and Radiopharm Theranostics tied by winning 5 of the 10 factors compared between the two stocks. Get Radiopharm Theranostics News Delivered to You Automatically Sign up to receive the latest news and ratings for RADX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RADX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RADX vs. The Competition Export to ExcelMetricRadiopharm TheranosticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.95M$3.03B$5.50B$9.81BDividend YieldN/A2.28%4.59%4.13%P/E RatioN/A17.3829.9425.16Price / SalesN/A349.44445.68102.78Price / CashN/A40.7324.8128.01Price / BookN/A8.988.685.82Net IncomeN/A-$54.75M$3.26B$265.22M7 Day Performance-3.43%-0.94%0.61%0.75%1 Month Performance22.46%7.33%3.33%1.97%1 Year PerformanceN/A23.30%45.75%27.33% Radiopharm Theranostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RADXRadiopharm TheranosticsN/A$5.07+7.6%$15.00+195.9%N/A$39.95MN/A0.00N/AGap DownIOBTIO Biotech3.2497 of 5 stars$2.23+5.2%$9.33+318.5%-25.5%$146.91MN/A-1.5030Trending NewsAnalyst ForecastGap UpHigh Trading VolumeGLSIGreenwich LifeSciences1.8208 of 5 stars$10.94-2.8%$39.00+256.5%-7.6%$146.27MN/A-8.683News CoveragePositive NewsUpcoming EarningsACOGAlpha Cognition1.5452 of 5 stars$9.11-1.8%$20.00+119.5%N/A$145.94MN/A-7.59N/ACCCCC4 Therapeutics2.7307 of 5 stars$2.05-5.1%$12.00+485.4%-55.3%$145.57M$35.58M-1.39150News CoverageEarnings ReportAnalyst DowngradeAnalyst RevisionNVCTNuvectis Pharma2.5181 of 5 stars$6.96-7.8%$17.00+144.3%-9.6%$145.39MN/A-6.168News CoverageEarnings ReportHigh Trading VolumeTHTXTheratechnologiesN/A$3.15flatN/A+131.9%$144.84M$84.38M-16.58140Positive NewsCLLSCellectis2.4653 of 5 stars$2.51-6.0%$4.00+59.4%+27.4%$139.52M$47.63M-2.92290Gap UpSPROSpero Therapeutics3.8613 of 5 stars$2.32+6.9%$5.00+115.5%+71.9%$129.71M$28.30M-1.81150CGENCompugen1.7806 of 5 stars$1.45+0.7%$4.00+175.9%-14.3%$129.40M$27.86M-9.0670News CoverageEarnings ReportAnalyst DowngradeAnalyst RevisionGap DownGNLXGenelux1.6974 of 5 stars$3.39-4.0%$17.75+423.6%+54.0%$128.01M$10K-3.8510Positive NewsEarnings ReportUpcoming Earnings Related Companies and Tools Related Companies IOBT Competitors GLSI Competitors ACOG Competitors CCCC Competitors NVCT Competitors THTX Competitors CLLS Competitors SPRO Competitors CGEN Competitors GNLX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RADX) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Radiopharm Theranostics Limited - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Radiopharm Theranostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.